Overview
This year's Targeted Therapies in Lung Cancer meeting featured novel research on emerging combination immunotherapy approaches and targets such as KRAS, G12C, and HER2. The very relevant topic of effective therapeutic control of resistance to targeted therapies was a discussion point, as was the state of development of antibody–drug conjugates. To view these presentations and others, including those made by fellows and early-career faculty, log in to the Virtual Library.
The Virtual Library is available to all IASLC members and meeting attendees (nonmembers must use their badge IDs for log in). Join IASLC today to access this and numerous other benefits. Become an IASLC member.
Venue: Fairmont Miramar Hotel & Bungalows
Related Files
Healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.
Meeting Chairs:
- Paul A. Bunn, Jr., MD
- Roy Herbst, MD, PhD
- Suresh S. Ramalingam, MD
- Leora Horn, MD
For any inquiries, please contact meetings@iaslc.org.
Healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.
Meeting Chairs:
- Paul A. Bunn, Jr., MD
- Roy Herbst, MD, PhD
- Suresh S. Ramalingam, MD
- Leora Horn, MD
For any inquiries, please contact meetings@iaslc.org.